colistimethate sodium - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
COLISTIN LINK colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 IU) powder for injection vial AUST R: 14667 Active ingredients: colistimethate sodium Dosage form: Injection, powder for Sponsor: Link Medical Products Pty Ltd T/A Link Pharmaceuticals Phone: 1800 181 060	Deletion from market: 31 May 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme.

Product details

Supply Impact Dates

Further Details

COLISTIN LINK colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 IU) powder for injection vial
AUST R: 14667
Active ingredients:
colistimethate sodium

Dosage form:
Injection, powder for

Sponsor:
Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Phone:
1800 181 060

Deletion from market:
31 May 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme.